List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 863 studies with search of:   United States, Hawaii
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cetuximab;   Drug: paclitaxel
2 Active, not recruiting Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CMF regimen;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Procedure: adjuvant therapy
3 Active, not recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
4 Recruiting Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: conventional surgery
5 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
6 Recruiting Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
Condition: Breast Cancer
Intervention: Procedure: chemotherapy
7 Recruiting Combination Chemotherapy in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
8 Active, not recruiting Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: placebo;   Drug: sorafenib tosylate
9 Active, not recruiting Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin
10 Recruiting Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
11 Active, not recruiting CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Drug: temsirolimus
12 Active, not recruiting Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: cyclophosphamide;   Drug: dexamethasone;   Drug: filgrastim;   Drug: melphalan;   Drug: prednisone;   Drug: sargramostim;   Drug: thalidomide;   Procedure: peripheral blood stem cell transplantation
13 Active, not recruiting Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
Condition: Kidney Cancer
Interventions: Drug: bevacizumab;   Drug: recombinant interferon alfa
14 Recruiting Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel;   Drug: placebo
15 Recruiting Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: filgrastim;   Drug: paclitaxel;   Drug: pegfilgrastim;   Drug: trastuzumab
16 Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: letrozole;   Drug: placebo
17 Active, not recruiting Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
Conditions: Cancer-Related Problem/Condition;   Prostate Cancer
Intervention: Drug: gabapentin
18 Recruiting Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
19 Active, not recruiting Bevacizumab or Cetuximab Combined With Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
Condition: Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: cetuximab;   Drug: gemcitabine hydrochloride;   Procedure: radiation therapy
20 Active, not recruiting Sorafenib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Drug: sorafenib tosylate

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services